Academic publisher Sage has announced the acquisition of Mary Ann Liebert, Inc., a global media company known for its specialized scientific, medical, and life sciences journals. The acquisition includes over 100 peer-reviewed journals and notable B2B media brands like Genetic Engineering & Biotechnology News (GEN) and Inside Precision Medicine.
Mary Ann Liebert, Inc., founded in 1980, is recognized for pioneering research in biotechnology, clinical medicine, public health, and emerging scientific fields. The company has been instrumental in launching influential journals such as AIDS Research & Human Retroviruses, The CRISPR Journal, and recent titles like AI in Precision Oncology and AI in Neuroscience.
Under this acquisition, Mary Ann Liebert, Inc. will retain its branding for its existing journals. Additionally, select Sage life sciences and medical journals will now be published under the Mary Ann Liebert, Inc. imprint.
Key titles from Mary Ann Liebert, Inc. are leaders in their fields, such as:
• Diabetes Technology & Therapeutics (medical laboratory technology)
• Autism in Adulthood (ranked first in Development Psychology and Rehabilitation)
• Advances in Wound Care (ranked second in emergency medicine)
The acquisition also includes the company’s robust multimedia offerings, such as webinars, summits, podcasts, and eBooks.
Sage aims to ensure a seamless transition for authors, editors, and readers while maintaining the high standards of publishing quality and customer service that both companies are known for.
This strategic move bolsters Sage’s commitment to advancing scientific research and reinforces its position as a key player in the academic publishing industry.
Click here to read the original press release.
